Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021

 

Upgrades

  • Zelman upgraded the previous rating for Armstrong World Industries Inc AWI from Hold to Buy. For the first quarter, Armstrong World Indus had an EPS of $0.84, compared to year-ago quarter EPS of $1.10. The current stock performance of Armstrong World Indus shows a 52-week-high of $110.53 and a 52-week-low of $57.96. Moreover, at the end of the last trading period, the closing price was at $105.79.
  • Guggenheim upgraded the previous rating for Aptiv PLC APTV from Neutral to Buy. Aptiv earned $1.06 in the first quarter, compared to $0.68 in the year-ago quarter. The current stock performance of Aptiv shows a 52-week-high of $160.14 and a 52-week-low of $73.36. Moreover, at the end of the last trading period, the closing price was at $152.75.
  • SVB Leerink upgraded the previous rating for Intersect ENT Inc XENT from Market Perform to Outperform. For the first quarter, Intersect ENT had an EPS of $0.51, compared to year-ago quarter EPS of $0.54. At the moment, the stock has a 52-week-high of $26.98 and a 52-week-low of $11.66. Intersect ENT closed at $15.97 at the end of the last trading period.
  • B of A Securities upgraded the previous rating for Bed Bath & Beyond Inc BBBY from Neutral to Buy. In the fourth quarter, Bed Bath & Beyond showed an EPS of $0.40, compared to $0.38 from the year-ago quarter. The current stock performance of Bed Bath & Beyond shows a 52-week-high of $53.90 and a 52-week-low of $7.39. Moreover, at the end of the last trading period, the closing price was at $29.31.
  • Deutsche Bank upgraded the previous rating for MGM Resorts International MGM from Hold to Buy. For the first quarter, MGM Resorts Intl had an EPS of $0.68, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $44.40 and a 52-week-low of $14.65. MGM Resorts Intl closed at $43.12 at the end of the last trading period.
  • For Lear Corp LEA, Goldman Sachs upgraded the previous rating of Neutral to Buy. For the first quarter, Lear had an EPS of $3.73, compared to year-ago quarter EPS of $2.05. At the moment, the stock has a 52-week-high of $204.91 and a 52-week-low of $102.17. Lear closed at $177.00 at the end of the last trading period.
  • According to Goldman Sachs, the prior rating for Magna International Inc MGA was changed from Neutral to Buy. Magna International earned $1.86 in the first quarter, compared to $0.86 in the year-ago quarter. At the moment, the stock has a 52-week-high of $104.28 and a 52-week-low of $42.37. Magna International closed at $92.93 at the end of the last trading period.
  • Keybanc upgraded the previous rating for EMCOR Group Inc EME from Sector Weight to Overweight. For the first quarter, EMCOR Gr had an EPS of $1.54, compared to year-ago quarter EPS of $1.35. The stock has a 52-week-high of $129.45 and a 52-week-low of $58.72. At the end of the last trading period, EMCOR Gr closed at $121.89.

See all analyst ratings upgrades.

 

Downgrades

  • According to CJS Securities, the prior rating for Raven Industries Inc RAVN was changed from Market Outperform to Market Perform. In the first quarter, Raven Industries showed an EPS of $0.26, compared to $0.19 from the year-ago quarter. The stock has a 52-week-high of $58.30 and a 52-week-low of $19.84. At the end of the last trading period, Raven Industries closed at $58.06.
  • For Invitation Homes Inc INVH, Zelman downgraded the previous rating of Buy to Hold. For the first quarter, Invitation Homes had an EPS of $0.36, compared to year-ago quarter EPS of $0.34. At the moment, the stock has a 52-week-high of $38.01 and a 52-week-low of $26.35. Invitation Homes closed at $37.61 at the end of the last trading period.
  • HC Wainwright & Co. downgraded the previous rating for Liminal Biosciences Inc LMNL from Buy to Neutral. Liminal Biosciences earned $0.66 in the first quarter. At the moment, the stock has a 52-week-high of $31.45 and a 52-week-low of $3.51. Liminal Biosciences closed at $4.07 at the end of the last trading period.
  • According to HSBC, the prior rating for BP PLC BP was changed from Buy to Hold. In the first quarter, BP showed an EPS of $0.78, compared to $0.24 from the year-ago quarter. At the moment, the stock has a 52-week-high of $28.49 and a 52-week-low of $14.74. BP closed at $27.23 at the end of the last trading period.
  • For Dollar Tree Inc DLTR, Piper Sandler downgraded the previous rating of Overweight to Neutral. In the first quarter, Dollar Tree showed an EPS of $1.60, compared to $1.04 from the year-ago quarter. The stock has a 52-week-high of $120.37 and a 52-week-low of $84.41. At the end of the last trading period, Dollar Tree closed at $101.49.

See all analyst ratings downgrades.

 

Initiations

  • Craig-Hallum initiated coverage on Sierra Wireless Inc SWIR with a Buy rating. The price target for Sierra Wireless is set to $22.00. For the first quarter, Sierra Wireless had an EPS of $0.26, compared to year-ago quarter EPS of $0.41. The stock has a 52-week-high of $22.22 and a 52-week-low of $8.25. At the end of the last trading period, Sierra Wireless closed at $16.70.
  • MoffettNathanson initiated coverage on Electronic Arts Inc EA with a Neutral rating. The price target for Electronic Arts is set to $151.00. For the fourth quarter, Electronic Arts had an EPS of $1.23, compared to year-ago quarter EPS of $1.08. The current stock performance of Electronic Arts shows a 52-week-high of $150.30 and a 52-week-low of $110.15. Moreover, at the end of the last trading period, the closing price was at $138.62.
  • MoffettNathanson initiated coverage on Take-Two Interactive Software Inc TTWO with a Buy rating. The price target for Take-Two Interactive is set to $214.00. In the fourth quarter, Take-Two Interactive showed an EPS of $1.40, compared to $1.50 from the year-ago quarter. At the moment, the stock has a 52-week-high of $214.91 and a 52-week-low of $136.81. Take-Two Interactive closed at $171.88 at the end of the last trading period.
  • MoffettNathanson initiated coverage on Activision Blizzard Inc ATVI with a Buy rating. The price target for Activision Blizzard is set to $124.00. Activision Blizzard earned $0.84 in the first quarter, compared to $0.58 in the year-ago quarter. The current stock performance of Activision Blizzard shows a 52-week-high of $104.53 and a 52-week-low of $71.19. Moreover, at the end of the last trading period, the closing price was at $90.79.
  • With an Overweight rating, Cantor Fitzgerald initiated coverage on Lipocine Inc LPCN. The price target seems to have been set at $3.00 for Lipocine. In the first quarter, Lipocine showed an EPS of $0.04, compared to $0.14 from the year-ago quarter. The stock has a 52-week-high of $2.42 and a 52-week-low of $1.02. At the end of the last trading period, Lipocine closed at $1.36.
  • Cantor Fitzgerald initiated coverage on Paya Holdings Inc PAYA with an Overweight rating. The price target for Paya Holdings is set to $14.00. Interestingly, in the first quarter, Paya Holdings's EPS was $0.07. The stock has a 52-week-high of $15.00 and a 52-week-low of $8.99. At the end of the last trading period, Paya Holdings closed at $10.76.
  • With a Neutral rating, UBS initiated coverage on Public Storage PSA. The price target seems to have been set at $310.00 for Public Storage. In the first quarter, Public Storage showed an EPS of $3.08, compared to $2.58 from the year-ago quarter. The stock has a 52-week-high of $305.59 and a 52-week-low of $183.22. At the end of the last trading period, Public Storage closed at $303.76.
  • Jefferies initiated coverage on Inovio Pharmaceuticals Inc INO with a Hold rating. The price target for Inovio Pharmaceuticals is set to $9.00. For the first quarter, Inovio Pharmaceuticals had an EPS of $0.27, compared to year-ago quarter EPS of $0.26. The current stock performance of Inovio Pharmaceuticals shows a 52-week-high of $33.79 and a 52-week-low of $5.81. Moreover, at the end of the last trading period, the closing price was at $8.69.
  • With a Buy rating, Needham initiated coverage on Analog Devices Inc ADI. The price target seems to have been set at $195.00 for Analog Devices. Analog Devices earned $1.54 in the second quarter, compared to $1.08 in the year-ago quarter. The stock has a 52-week-high of $168.93 and a 52-week-low of $110.47. At the end of the last trading period, Analog Devices closed at $163.63.
  • With a Buy rating, Truist Securities initiated coverage on Taysha Gene Therapies Inc TSHA. The price target seems to have been set at $60.00 for Taysha Gene Therapies. In the first quarter, Taysha Gene Therapies earned $0.87. At the moment, the stock has a 52-week-high of $33.35 and a 52-week-low of $18.16. Taysha Gene Therapies closed at $25.14 at the end of the last trading period.
  • With a Buy rating, Jefferies initiated coverage on Vaxart Inc VXRT. The price target seems to have been set at $13.00 for Vaxart. Vaxart earned $0.14 in the first quarter, compared to $0.02 in the year-ago quarter. At the moment, the stock has a 52-week-high of $24.90 and a 52-week-low of $2.58. Vaxart closed at $7.85 at the end of the last trading period.
  • Stifel initiated coverage on PLBY Group Inc PLBY with a Buy rating. The price target for PLBY Group is set to $52.00. In the first quarter, PLBY Group earned $0.15. The stock has a 52-week-high of $63.04 and a 52-week-low of $11.02. At the end of the last trading period, PLBY Group closed at $37.08.
  • Oppenheimer initiated coverage on Lightning eMotors Inc ZEV with an Outperform rating. The price target for Lightning eMotors is set to $15.00. Lightning eMotors earned $5.64 in the first quarter, compared to $1.10 in the year-ago quarter. The current stock performance of Lightning eMotors shows a 52-week-high of $9.62 and a 52-week-low of $5.84. Moreover, at the end of the last trading period, the closing price was at $7.63.
  • Goldman Sachs initiated coverage on TCR2 Therapeutics Inc TCRR with a Buy rating. The price target for TCR2 Therapeutics is set to $30.00. For the first quarter, TCR2 Therapeutics had an EPS of $0.58, compared to year-ago quarter EPS of $0.65. The current stock performance of TCR2 Therapeutics shows a 52-week-high of $35.86 and a 52-week-low of $12.95. Moreover, at the end of the last trading period, the closing price was at $17.45.
  • With a Buy rating, Stifel initiated coverage on Denbury Inc DEN. The price target seems to have been set at $93.00 for Denbury. Denbury earned $0.44 in the first quarter, compared to $0.06 in the year-ago quarter. At the moment, the stock has a 52-week-high of $80.27 and a 52-week-low of $15.43. Denbury closed at $76.96 at the end of the last trading period.
  • With a Buy rating, HC Wainwright & Co. initiated coverage on Kronos Bio Inc KRON. The price target seems to have been set at $35.00 for Kronos Bio. In the first quarter, Kronos Bio showed an EPS of $0.48, compared to $1.23 from the year-ago quarter. At the moment, the stock has a 52-week-high of $39.60 and a 52-week-low of $19.60. Kronos Bio closed at $23.85 at the end of the last trading period.
  • With a Buy rating, UBS initiated coverage on Colgate-Palmolive Co CL. The price target seems to have been set at $95.00 for Colgate-Palmolive. For the first quarter, Colgate-Palmolive had an EPS of $0.80, compared to year-ago quarter EPS of $0.75. The current stock performance of Colgate-Palmolive shows a 52-week-high of $86.41 and a 52-week-low of $71.21. Moreover, at the end of the last trading period, the closing price was at $80.25.
  • DA Davidson initiated coverage on Affirm Holdings Inc AFRM with a Buy rating. The price target for Affirm Holdings is set to $80.00. Interestingly, in the third quarter, Affirm Holdings's EPS was $1.06. The stock has a 52-week-high of $146.90 and a 52-week-low of $46.50. At the end of the last trading period, Affirm Holdings closed at $65.16.
  • With a Sell rating, UBS initiated coverage on Clorox Co CLX. The price target seems to have been set at $166.00 for Clorox. Clorox earned $1.62 in the third quarter, compared to $1.89 in the year-ago quarter. The current stock performance of Clorox shows a 52-week-high of $239.87 and a 52-week-low of $172.35. Moreover, at the end of the last trading period, the closing price was at $172.72.
  • With a Buy rating, UBS initiated coverage on The Scotts Miracle Gro Co SMG. The price target seems to have been set at $225.00 for Scotts Miracle Gro. Scotts Miracle Gro earned $5.64 in the second quarter, compared to $4.50 in the year-ago quarter. The stock has a 52-week-high of $254.34 and a 52-week-low of $126.75. At the end of the last trading period, Scotts Miracle Gro closed at $191.68.
  • UBS initiated coverage on Spectrum Brands Holdings Inc SPB with a Buy rating. The price target for Spectrum Brands Holdings is set to $102.00. For the second quarter, Spectrum Brands Holdings had an EPS of $1.76, compared to year-ago quarter EPS of $0.91. At the moment, the stock has a 52-week-high of $97.27 and a 52-week-low of $43.09. Spectrum Brands Holdings closed at $82.10 at the end of the last trading period.
  • With a Neutral rating, UBS initiated coverage on Procter & Gamble Co PG. The price target seems to have been set at $138.00 for Procter & Gamble. Procter & Gamble earned $1.26 in the third quarter, compared to $1.17 in the year-ago quarter. At the moment, the stock has a 52-week-high of $146.92 and a 52-week-low of $115.04. Procter & Gamble closed at $132.93 at the end of the last trading period.
  • UBS initiated coverage on The Estee Lauder Companies Inc EL with a Neutral rating. The price target for Estee Lauder Cos is set to $323.00. For the third quarter, Estee Lauder Cos had an EPS of $1.62, compared to year-ago quarter EPS of $0.86. The stock has a 52-week-high of $318.34 and a 52-week-low of $183.22. At the end of the last trading period, Estee Lauder Cos closed at $302.38.
  • With a Neutral rating, UBS initiated coverage on Church & Dwight Co Inc CHD. The price target seems to have been set at $85.00 for Church & Dwight Co. Church & Dwight Co earned $0.83 in the first quarter, compared to $0.83 in the year-ago quarter. The stock has a 52-week-high of $98.96 and a 52-week-low of $75.42. At the end of the last trading period, Church & Dwight Co closed at $83.05.
  • UBS initiated coverage on YETI Holdings Inc YETI with a Neutral rating. The price target for YETI Holdings is set to $95.00. In the first quarter, YETI Holdings showed an EPS of $0.38, compared to $0.11 from the year-ago quarter. At the moment, the stock has a 52-week-high of $95.76 and a 52-week-low of $40.10. YETI Holdings closed at $89.43 at the end of the last trading period.
  • With a Neutral rating, UBS initiated coverage on Reynolds Consumer Products Inc REYN. The price target seems to have been set at $32.00 for Reynolds Consumer. Reynolds Consumer earned $0.36 in the first quarter, compared to $0.30 in the year-ago quarter. The current stock performance of Reynolds Consumer shows a 52-week-high of $35.73 and a 52-week-low of $27.27. Moreover, at the end of the last trading period, the closing price was at $29.72.
  • DA Davidson initiated coverage on Square Inc SQ with a Buy rating. The price target for Square is set to $275.00. In the first quarter, Square showed an EPS of $0.41, compared to $0.02 from the year-ago quarter. The current stock performance of Square shows a 52-week-high of $283.19 and a 52-week-low of $98.93. Moreover, at the end of the last trading period, the closing price was at $238.70.
  • DA Davidson initiated coverage on PayPal Holdings Inc PYPL with a Buy rating. The price target for PayPal Holdings is set to $325.00. For the first quarter, PayPal Holdings had an EPS of $1.22, compared to year-ago quarter EPS of $0.66. At the moment, the stock has a 52-week-high of $309.14 and a 52-week-low of $164.29. PayPal Holdings closed at $288.12 at the end of the last trading period.
  • Daiwa Capital initiated coverage on Okta Inc OKTA with a Buy rating. The price target for Okta is set to $282.00. For the first quarter, Okta had an EPS of $0.10, compared to year-ago quarter EPS of $0.07. The current stock performance of Okta shows a 52-week-high of $294.00 and a 52-week-low of $185.05. Moreover, at the end of the last trading period, the closing price was at $242.49.

See all analyst ratings initiations.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: UpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsBZI-Ratings
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!